文献速递腹部MR

钆贝葡胺经胆道排泄导致磁共振胰胆管成像质量下降

Biliary excretion of gadobenate dimeglumine causing degradation of magnetic resonance cholangiopancreatography (MRCP).
PubMed 文献 · Abdom Radiol (NY) · 2020-08-02

回顾性分析14个月内静脉注射钆贝葡胺或钆布醇后获得的二维磁共振胰胆管成像,由五位腹部放射科医生按3分法评估胆管和胰管清晰度。钆贝葡胺组胆管各段评分低于钆布醇组,且随动脉期至磁共振胰胆管成像采集延迟增加而下降;作者认为二维磁共振胰胆管成像应在动脉期后7.2分钟内完成。

要点

  • 钆贝葡胺增强后二维磁共振胰胆管成像的胆管清晰度随动脉期后延迟增加而下降。
  • 钆贝葡胺组胆管各段平均评分2.1-2.6,低于钆布醇组的2.8-2.9。
  • 钆贝葡胺组所有胆管段良好显示对应延迟为7.2-9.4分钟(均值8.3分钟)。

关键影像表现/征象

  • 胆管清晰度评分随钆贝葡胺注射后动脉期至磁共振胰胆管成像采集延迟变化(p≤0.047)。
  • 钆贝葡胺组胆管各段平均评分2.1-2.6,钆布醇组2.8-2.9(p≤0.006)。
  • 胰管显示平均评分两组间无差异(p=0.66)。
  • 钆贝葡胺组所有胆管段良好显示对应延迟为7.2-9.4分钟(95%置信区间;均值8.3分钟)。

诊断标准与关键数值

  • 采用3分法评估胆管和胰管清晰度:1分为未显示,2分为有限显示,3分为良好显示。
  • 胰管显示组内相关系数提示中等信度,肝内胆管及上、下段肝外胆管显示提示极好信度。
  • 钆贝葡胺组胆管各段平均评分2.1-2.6,低于钆布醇组的2.8-2.9(p≤0.006)。
  • 钆贝葡胺组所有胆管段良好显示的延迟为7.2-9.4分钟(95%置信区间;均值8.3分钟)。

临床应用与阅片要点

  • 使用钆贝葡胺增强时,二维磁共振胰胆管成像应在动脉期后7.2分钟内采集以保证胆管良好显示。
  • 钆贝葡胺增强后延迟延长可导致胆管清晰度下降,判读时需结合延迟时间。
  • 胰管显示不受钆贝葡胺与钆布醇差异影响(p=0.66)。
  • 作者建议二维磁共振胰胆管成像在动脉期序列后7.2分钟内完成。

局限性

  • 原文为回顾性研究。
  • 钆布醇组仅纳入延迟≥15分钟的检查。
  • 钆贝葡胺组107例与钆布醇组27例样本量不一致。
  • 原文结论基于观察性数据,需进一步研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To assess the effect of gadobenate dimeglumine on magnetic resonance cholangiopancreatography (MRCP) and determine an appropriate time frame for performing MRCP sequences.

MATERIALS AND METHODS: 2D MRCP sequences obtained after intravenous administration of gadobenate dimeglumine or gadobutrol over 14 months were reviewed retrospectively in randomized order by five abdominal radiologists, using a 3-point scale to rate biliary and pancreatic duct clarity (1 = no-, 2 = limited-, 3 = good visualization). Intraclass correlation coefficients were computed and mean scores were compared for both agents. For gadobenate dimeglumine exams, time delays between arterial phase and MRCP acquisition times were analyzed concerning duct clarity. For gadobutrol, only exams with delays ≥ 15 min were included.

RESULTS: 134 exams (107 gadobenate dimeglumine, 27 gadobutrol) were included. Moderate reliability for pancreatic duct visualization and excellent reliability for visualization of intrahepatic bile ducts and upper and lower extrahepatic bile ducts were noted. No difference in mean scores was noted for pancreatic duct visualization (p = 0.66). Bile duct segment scores were lower with gadobenate dimeglumine (mean: 2.1-2.6) compared with gadobutrol (mean: 2.8-2.9) (p ≤ 0.006). For gadobenate dimeglumine, visualization scores varied depending on the delay between the arterial phase and MRCP acquisition (p ≤ 0.047). Good visualization for all bile duct segments was noted with delays of 7.2-9.4 min (95% confidence interval; mean 8.3 min).

CONCLUSION: Bile duct clarity degraded on MRCP images with an increasing delay following gadobenate dimeglumine injection. 2D MRCP, thus, should be performed within 7.2 min after obtaining the arterial phase sequence to ensure good visualization of the entire biliary system.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Trunz LM, Guglielmo FF, Selvarajan SK, et al. Biliary excretion of gadobenate dimeglumine causing degradation of magnetic resonance cholangiopancreatography (MRCP). Abdom Radiol (NY). 2020. PMID: 32743690. doi:10.1007/s00261-020-02686-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。